100 Global View Drive
Warrendale , PA 15086
USA
Related Content
Aug. 30, 2026 — Bayer has announced the presentation of first detailed results from the Phase III REVEAL study, an ...
September 02, 2026
Aug. 20, 2026 — Bayer has announced that 11 oral presentations across its cardiovascular, kidney, and secondary stroke ...
August 20, 2026
May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...
May 07, 2026
July 14, 2025 — Bayer has announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA (finerenone) to ...
July 14, 2025
June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...
June 11, 2025
June 3, 2025 — Bayer announced it will present multiple new analyses of the Kerendia (finerenone) clinical trial program ...
June 04, 2025
March 25, 2025 — Bayer plans to present data from 13 new analyses from across the KERENDIA (finerenone) comprehensive ...
March 25, 2025
March 17, 2025 — Bayer recently announced that the U.S. Food and Drug Administration (FDA) accepted its supplemental new ...
March 21, 2025
May 17, 2024 — The study design and baseline characteristics of FINE-HEART, a new prespecified, exploratory pooled ...
May 17, 2024
April 18, 2024 — Bayer AG and Asklepios BioPharmaceutical, Inc., a gene therapy company wholly owned and independently ...
April 18, 2024